Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD27) (HUMAN MONOCLONAL CDX-1127 CLONE 1F5 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CDX-1127 CLONE 1F5 .KAPPA.-CHAIN, DIMER

Large B-Cell Lymphoma With IRF4 Rearrangement

National Cancer Institute (NCI)monoclonal_antibodyPhase 2Active
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
29/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Large B-Cell Lymphoma With IRF4 Rearrangement cohort.

Asset / SponsorPhaseRating
Nivolumab
National Cancer Institute (NCI)
Phase 2CCC
VINCRISTINE SULFATE
Northwestern University
Phase 2CCC
Zanubrutinib
Northwestern University
Phase 2CCC
Golcadomide
Mayo Clinic
Phase 2CCC
PREDNISONE TABLETS
Northwestern University
Phase 2CCC
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Mayo Clinic
Phase 2CCC
Inno-206
Northwestern University
Phase 2CCC
Cyclophosphamide
Northwestern University
Phase 2CCC

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD ANTIGEN CD27) (HUMAN MONOCLONAL CDX-1127 CLONE 1F5 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CDX-1127 CLONE 1F5 .KAPPA.-CHAIN, DIMER is also rated in:

B-cell non-Hodgkin lymphomaDormant
CCC
Indicative ·
51 / 100
View asset →
melanomaDormant
CCC
Indicative ·
49 / 100
View asset →
Advanced Ovarian CarcinomaDormant
CCC
Indicative ·
49 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →